Impaired RelA signaling and lipid metabolism dysregulation in hepatocytes: driving forces in the progression of metabolic dysfunction-associated steatotic liver disease
Abstract RelA, also known as nuclear factor kappa B p65, plays a crucial role in the pathogenesis of various liver diseases. However, the specific role of RelA in hepatocytes during the progression of metabolic dysfunction-associated steatotic liver disease (MASLD) is not well understood. This study...
Saved in:
Main Authors: | Yihuai He, Jinlian Jiang, Lili Ou, Yunfen Chen, Aikedaimu Abudukeremu, Guimei Chen, Weiwei Zhong, Zhigang Jiang, Nuerbiye Nuermaimaiti, Yaqun Guan |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2025-02-01
|
Series: | Cell Death Discovery |
Online Access: | https://doi.org/10.1038/s41420-025-02312-3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dynamics of REL, RELA and IRF1 transcription factor expression in U937 macrophages after dioxin exposure
by: E. V. Kashina, et al.
Published: (2017-02-01) -
Metabolic dysfunction-associated steatotic liver disease
by: Chieh Chen, et al.
Published: (2024-12-01) -
Toxin-antitoxin genes are differentially expressed in Escherichia coli relA and spoT mutans cultured under nitrogen, fatty acid, or carbon starvation conditions
by: Monika Maciąg-Dorszyńska, et al.
Published: (2025-01-01) -
Evidence summary of lifestyle interventions in adults with metabolic dysfunction-associated steatotic liver disease
by: Mei-jing Chen, et al.
Published: (2025-01-01) -
Retinopathy in Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Myrsini Orfanidou, et al.
Published: (2024-12-01)